Compare ATEC & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEC | PAHC |
|---|---|---|
| Founded | 1990 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2006 | 2014 |
| Metric | ATEC | PAHC |
|---|---|---|
| Price | $10.72 | $38.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | $15.79 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 2.3M | 197.7K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | 15.04 | ★ 104.20 |
| EPS | N/A | ★ 2.43 |
| Revenue | $101,739,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $15.43 | $3.83 |
| Revenue Next Year | $15.24 | $3.49 |
| P/E Ratio | ★ N/A | $15.39 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $6.82 | $28.25 |
| 52 Week High | $23.29 | $60.08 |
| Indicator | ATEC | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.70 | 64.46 |
| Support Level | $10.61 | $38.29 |
| Resistance Level | $11.03 | $40.65 |
| Average True Range (ATR) | 0.39 | 1.32 |
| MACD | 0.01 | 0.34 |
| Stochastic Oscillator | 80.71 | 89.12 |
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.